XML 81 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations
3 Months Ended
Jul. 27, 2012
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations Disclosure

Note 3 – Discontinued Operations

 

Beginning in the third quarter of fiscal year 2012, the results of operations, assets, and liabilities of the Physio-Control business, which were previously presented as a component of the Cardiac and Vascular Group operating segment, are classified as discontinued operations.

 

On January 30, 2012, the Company completed the sale of the Physio-Control business to Bain Capital Partners, LLC. The Company sold $164 million in net assets and received $386 million in net cash, excluding potential earn-outs. Additionally, the Company entered into a Transition Services Agreement (TSA) with Physio-Control in which the Company is providing transition services to ensure continuity of business for Physio-Control as it establishes stand-alone processes separate from Medtronic. The TSA requires the Company to continue to provide certain back-office support functions to Physio-Control in the areas of finance, facilities, human resources, customer service, IT, quality and regulatory, and operations. The timeframe for these services ranges from three to 12 months following the closing date. The Company is being compensated for the services specified in the TSA. The Company records the income earned from the TSA in other expense, net in the condensed consolidated statements of earnings.

 

The following is a summary of the operating results of Physio-Control for discontinued operations for the three months ended July 29, 2011:

 

 Three months ended
 July 29,
(in millions)2011
Discontinued operations:  
Net sales$ 103
   
Earnings from operations of Physio-Control$ 8
Physio-Control divestiture-related costs  (5)
Income tax expense  (1)
Earnings from discontinued operations$ 2
   

As Physio-Control was sold on January 30, 2012, only the prior period results are presented in the table above.

 

The Company reclassified $5 million of Physio-Control divestiture-related costs previously recorded in acquisition-related items within continuing operations on the condensed consolidated statements of earnings in the first quarter of fiscal year 2012 to discontinued operations. For further information on Physio-Control assets and liabilities sold, see Note 3 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended April 27, 2012.